{"title": "Los pacientes con c\u00e1ncer responden bien a las vacunas frente al covid-19, seg\u00fan un estudio", "author": "Diariofarma", "url": "https://diariofarma.com/2021/07/05/los-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio", "hostname": "diariofarma.com", "description": "El 94% de los pacientes oncol\u00f3gicos desarroll\u00f3 una buena respuesta inmunitaria a las vacunas de ARNm contra la covid-19 entre tres y cuatro semanas despu\u00e9s de recibir su segunda dosis, seg\u00fan un estudio realizado en Estados Unidos y Suiza.", "sitename": "Diariofarma", "date": "2021-07-05", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "El 94% de los\n[pacientes](https://diariofarma.com/tag/pacientes?utm_source=diariofarma&utm_medium=web&utm_campaign=smartlink) oncol\u00f3gicos desarroll\u00f3 una buena respuesta inmunitaria a las [vacunas](https://diariofarma.com/tag/vacunas?utm_source=diariofarma&utm_medium=web&utm_campaign=smartlink) de ARNm contra la [covid-19](https://diariofarma.com/tag/covid-19?utm_source=diariofarma&utm_medium=web&utm_campaign=smartlink) entre tres y cuatro semanas despu\u00e9s de recibir su segunda dosis, seg\u00fan un estudio realizado en Estados Unidos y [Suiza](https://diariofarma.com/tag/suiza?utm_source=diariofarma&utm_medium=web&utm_campaign=smartlink).\nEl estudio, publicado en \u2018Cancer Cell\u2019, incluy\u00f3 un total de 131 pacientes, de ellos solamente siete pacientes de alto riesgo no lo hicieron. Seg\u00fan se\u00f1ala uno de los autores del estudio, Dimpy P. Shah, del Centro de C\u00e1ncer Mays (Estados Unidos), \u201cno pudimos encontrar ning\u00fan anticuerpo contra el virus en esos pacientes\u201d. Y ello, seg\u00fan el autor, tiene implicaciones para el futuro, \u201c\u00bfDebemos suministrar una tercera dosis de la vacuna una vez finalizada la terapia contra el c\u00e1ncer en determinados pacientes de alto riesgo?\u201d, se pregunta.\n\u201cCon otras vacunas e infecciones, se ha demostrado que los pacientes con c\u00e1ncer no desarrollan una respuesta inmunitaria tan robusta como la poblaci\u00f3n general. Por lo tanto, ten\u00eda sentido plantear la hip\u00f3tesis de que ciertos grupos de pacientes de alto riesgo no tienen respuesta de anticuerpos a la vacuna contra la covid-19\u201d.\nLos pacientes sometidos a quimioterapia, que es t\u00f3xica para las c\u00e9lulas, desarrollaron una respuesta de anticuerpos, pero fue d\u00e9bil en comparaci\u00f3n con la poblaci\u00f3n general. \"Todav\u00eda no sabemos c\u00f3mo se relaciona esto con la protecci\u00f3n contra la covid-19\", destaca Shah.\nLa edad media de los pacientes del estudio era de 63 a\u00f1os. La mayor\u00eda de los pacientes (106) ten\u00edan c\u00e1nceres s\u00f3lidos, en contraposici\u00f3n a las neoplasias hematol\u00f3gicas (25). La poblaci\u00f3n del estudio era un 80 por ciento de blancos no hispanos, un 18 por ciento de hispanos y un 2 por ciento de negros.\n\u201cRecomendamos que en el futuro se realicen estudios tambi\u00e9n en pacientes negros, asi\u00e1ticos e hispanos, para ver si hay diferencias en la respuesta inmunitaria de la vacunaci\u00f3n\u201d, remacha Mesa. En el estudio no se examin\u00f3 la variante Delta ni otras del virus. El equipo tampoco analiz\u00f3 la respuesta de las c\u00e9lulas T y B que combaten la\n[infecci\u00f3n](https://diariofarma.com/tag/infeccion?utm_source=diariofarma&utm_medium=web&utm_campaign=smartlink) en los pacientes con c\u00e1ncer.\nS\u00edguenos en redes sociales", "language": null, "image": "https://diariofarma.com/wp-content/uploads/2019/12/Farmacia-hospitalaria-preparacion-medicamentos-quimioterapia-citostaticos-oncologia.jpg", "pagetype": "article", "links": ["#", "https://diariofarma.com/", "https://diariofarma.com/politica", "https://diariofarma.com/profesion", "https://diariofarma.com/gestion", "https://diariofarma.com/terapeutica", "https://diariofarma.com/opinion", "https://diariofarma.com/farmacia-asistencial-2", "https://diariofarma.com/farmacia-hospitalaria-3-2-2", "https://diariofarma.com/documentacion", "https://diariofarma.com/busqueda", "https://diariofarma.com/newsletter-2", "https://www.addtoany.com/add_to/facebook?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/twitter?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/whatsapp?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/linkedin?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/meneame?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/email?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/printfriendly?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/flipboard?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/share", "https://diariofarma.com/tag/covid-19", "https://diariofarma.com/tag/estados-unidos", "https://diariofarma.com/tag/hematologia", "https://diariofarma.com/tag/infeccion", "https://diariofarma.com/tag/oncologia", "https://diariofarma.com/tag/quimioterapia", "https://diariofarma.com/tag/suiza", "https://diariofarma.com/tag/vacunas", "https://www.addtoany.com/add_to/facebook?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/twitter?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/whatsapp?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/linkedin?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/meneame?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/email?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/printfriendly?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/flipboard?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/share", "https://diariofarma.com/2023/09/25/9-de-cada-10-centros-no-analiza-las-superficies-donde-se-preparan-farmacos-peligrosos-segun-enfermeria", "https://diariofarma.com/2023/09/24/la-farmacia-reivindica-su-papel-como-fortalecedor-del-sistema", "https://diariofarma.com/2023/09/24/minones-se-compromete-a-desarrollar-el-programa-de-farmacia-rural-antes-de-final-de-ano", "https://diariofarma.com/2023/09/24/solis-busca-consensuar-una-formula-que-permita-elevar-los-incentivos-a-la-innovacion-en-vez-de-reducirlos", "https://diariofarma.com/2023/09/21/ecdc-una-alta-vacunacion-puede-reducir-una-de-cada-tres-hospitalizaciones-por-covid-en-otono", "https://diariofarma.com/tag/pacientes?utm_source=diariofarma&utm_medium=web&utm_campaign=smartlink", "https://diariofarma.com/tag/vacunas?utm_source=diariofarma&utm_medium=web&utm_campaign=smartlink", "https://diariofarma.com/tag/covid-19?utm_source=diariofarma&utm_medium=web&utm_campaign=smartlink", "https://diariofarma.com/tag/suiza?utm_source=diariofarma&utm_medium=web&utm_campaign=smartlink", "https://diariofarma.com/tag/infeccion?utm_source=diariofarma&utm_medium=web&utm_campaign=smartlink", "https://twitter.com/diariofarma", "https://www.addtoany.com/add_to/facebook?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/twitter?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/whatsapp?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/linkedin?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/meneame?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/email?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/printfriendly?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/add_to/flipboard?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio", "https://www.addtoany.com/share", "https://www.diariofarma.com?&utm_source=portadabajo_noticia", "https://diariofarma.com/2022/03/10/europa-aprobo-54-nuevos-medicamentos-en-2021", "https://diariofarma.com/2022/03/10/europa-aprobo-54-nuevos-medicamentos-en-2021", "https://diariofarma.com/2021/10/20/el-trasplante-de-medula-osea-y-la-car-t-son-y-seran-complementarios-frente-al-cancer-hematologico", "https://diariofarma.com/2021/10/20/el-trasplante-de-medula-osea-y-la-car-t-son-y-seran-complementarios-frente-al-cancer-hematologico", "https://diariofarma.com/2021/02/02/las-agencias-reguladoras-convierten-a-2020-en-uno-de-los-anos-mas-fructiferos-en-nuevas-aprobaciones", "https://diariofarma.com/2021/02/02/las-agencias-reguladoras-convierten-a-2020-en-uno-de-los-anos-mas-fructiferos-en-nuevas-aprobaciones", "https://diariofarma.com/2023/09/15/farmaindustria-saluda-la-apuesta-por-la-reindustrializacion-pero-pide-mas-innovacion", "https://diariofarma.com/2023/09/15/farmaindustria-saluda-la-apuesta-por-la-reindustrializacion-pero-pide-mas-innovacion", "https://diariofarma.com/2022/11/02/facme-asegura-que-las-vacunas-adaptadas-generan-una-respuesta-mayor-frente-a-las-variantes-del-covid", "https://diariofarma.com/2022/11/02/facme-asegura-que-las-vacunas-adaptadas-generan-una-respuesta-mayor-frente-a-las-variantes-del-covid", "https://diariofarma.com/2022/06/06/tecartus-se-consolida-con-resultados-a-largo-plazo", "https://diariofarma.com/2022/06/06/tecartus-se-consolida-con-resultados-a-largo-plazo", "https://diariofarma.com/2022/05/27/los-medicamentos-cuestion-de-genero", "https://diariofarma.com/2022/05/27/los-medicamentos-cuestion-de-genero", "https://diariofarma.com/2022/02/04/el-cancer-no-puede-desaparecer-de-las-prioridades-sanitarias-ni-de-su-agenda", "https://diariofarma.com/2022/02/04/el-cancer-no-puede-desaparecer-de-las-prioridades-sanitarias-ni-de-su-agenda", "https://diariofarma.com/2021/12/09/viatris-lanza-un-test-de-deteccion-de-anticuerpos-post-vacunacion-de-covid-19", "https://diariofarma.com/2021/12/09/viatris-lanza-un-test-de-deteccion-de-anticuerpos-post-vacunacion-de-covid-19", "https://diariofarma.com/2021/11/23/en-2022-probablemente-la-ema-recibira-el-primer-producto-de-terapia-genica-para-curar-la-hemofilia", "https://diariofarma.com/2021/11/23/en-2022-probablemente-la-ema-recibira-el-primer-producto-de-terapia-genica-para-curar-la-hemofilia", "https://diariofarma.com/2021/09/09/grupo-espanol-de-linfomas-los-pacientes-que-han-recibido-car-t-pueden-responder-peor-a-la-vacuna", "https://diariofarma.com/2021/09/09/grupo-espanol-de-linfomas-los-pacientes-que-han-recibido-car-t-pueden-responder-peor-a-la-vacuna", "https://diariofarma.com/2021/09/07/los-anticuerpos-monoclonales-en-primera-linea-de-tratamiento-mejoran-la-supervivencia-en-mieloma-multiple", "https://diariofarma.com/2021/09/07/los-anticuerpos-monoclonales-en-primera-linea-de-tratamiento-mejoran-la-supervivencia-en-mieloma-multiple", "https://www.kernpharmacias.com/s/", "http://www.msd.es/?utm_source=diariofarma&utm_medium=display&utm_campaign=comunicaci%C3%B3n_2018&utm_content=banner_300x250", "https://www.diariofarma.com/newsletter?utm_source=banner_lateral_nwlett", "https://www.diariofarma.com/linkout/27673", "https://www.kernpharma.com/es/actividad/finisher", "https://www.diariofarma.com/2020/10/19/las-agencias-van-a-evaluar-las-vacunas-con-el-rigor-de-siempre-haciendo-oidos-sordos-a-la-urgencia?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2020/10/18/soy-vehemente-ante-alguien-que-me-dice-que-la-farmacia-no-es-clinica?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2020/02/18/no-apoyamos-el-multiswitch-es-malo-para-el-paciente-y-para-el-sns?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2019/11/24/llevo-20-anos-escuchando-que-el-sns-no-es-sostenible-pero-somos-el-sistema-mas-eficiente-de-toda-europa?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2020/01/28/vamos-a-tener-avances-extraordinarios-y-las-decisiones-las-tendremos-que-tomar-entre-todos?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2019/12/02/con-vision-ambiciosa-y-de-reforma-profunda-cubriremos-temas-amplios?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2019/11/16/entrevista-con-patricia-lacruz-sobre-el-plan-de-genericos-y-biosimilares?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2019/10/19/vamos-a-seguir-edificando-sobre-lo-que-ya-nos-hemos-encontrado-que-es-muchisimo?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df\"", "https://www.diariofarma.com/2019/04/07/en-la-segunda-parte-del-partido-tenemos-que-consolidar-lo-realizado?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2019/03/31/las-decisiones-del-cisns-deben-ser-vinculantes-la-cohesion-y-la-equidad-interterritorial-son-basicas?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2019/04/15/algunos-acuerdos-del-consejo-interterritorial-deben-ser-vinculantes?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2019/02/05/no-vamos-a-entrar-en-debates-con-los-proveedores-la-evidencia-nos-guiara?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2019/10/08/somos-punteros-en-tecnologia-nadie-en-el-mundo-esta-tan-avanzado?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2018/07/10/con-la-nueva-estrategia-de-cronicos-reordenamos-nuestros-recursos?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2019/01/15/debemos-unirnos-para-que-la-venta-por-internet-se-haga-colectivamente?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2018/10/24/la-atencion-domiciliaria-y-el-sft-lo-hacen-enfermeria-y-ap-y-debe-ser-asi?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2019/04/24/creemos-en-la-necesidad-de-ir-a-un-sistema-nuevo-de-pago-por-valor?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2018/11/15/el-farmaceutico-tiene-que-intervenir-antes-de-que-el-paciente-lo-necesite?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2018/01/14/valoraremos-una-accion-estrategica-abordar-la-factura-farmaceutica?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2017/11/25/siempre-pedimos-interterritorial-vinculante-tenemos-la-herramienta?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2017/11/22/potenciar-la-af-farmaceutico-no-solo-dispense-fundamental?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2017/09/20/importante-la-farmacia-crezca-queremos-preservar-modelo?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/2017/07/07/las-fusiones-pueden-racionalizar-la-actividad-las-distribuidoras?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "https://www.diariofarma.com/category/entrevista?&utm_source=descatadas&utm_medium=webdf&utm_campaign=destac_df", "\r\n/quienes-somos", "\r\nhttps://www.diariofarma.com/politica-de-cookies", "\r\nhttps://www.diariofarma.com/politica-de-privacidad", "\r\nhttps://www.diariofarma.com/aviso-legal", "\r\nhttps://sp.depositphotos.com/stock-photography.html", "\r\nmailto:df@diariofarma.com", "#", "https://www.addtoany.com/add_to/facebook?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio%20%7C%20%40diariofarma", "https://www.addtoany.com/add_to/twitter?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio%20%7C%20%40diariofarma", "https://www.addtoany.com/add_to/whatsapp?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio%20%7C%20%40diariofarma", "https://www.addtoany.com/add_to/linkedin?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio%20%7C%20%40diariofarma", "https://www.addtoany.com/add_to/meneame?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio%20%7C%20%40diariofarma", "https://www.addtoany.com/add_to/email?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio%20%7C%20%40diariofarma", "https://www.addtoany.com/add_to/printfriendly?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio%20%7C%20%40diariofarma", "https://www.addtoany.com/add_to/flipboard?linkurl=https%3A%2F%2Fdiariofarma.com%2F2021%2F07%2F05%2Flos-pacientes-con-cancer-responden-bien-a-las-vacunas-frente-al-covid-19-segun-un-estudio&linkname=Los%20pacientes%20con%20c%C3%A1ncer%20responden%20bien%20a%20las%20vacunas%20frente%20al%20covid-19%2C%20seg%C3%BAn%20un%20estudio%20%7C%20%40diariofarma", "https://www.addtoany.com/share", "https://www.diariofarma.com/politica-de-cookies", "http://wordpress.org/plugins/asesor-cookies-para-la-ley-en-espana/", "javascript:;", null, "#"]}